These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 5292721)

  • 41. Immunoglobulin and granulocyte cytochemical reactions in L-asparaginase treated children with acute lymphoblastic leukemia.
    Zajaczkowski L; Pituch A; Legutko L
    Med Interne; 1976; 14(3):191-5. PubMed ID: 1071477
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of L-asparaginase on the two cases of acute leukemia with mediastinal tumors as initial signs.
    Saito T; Himori T; Sugawara K; Ujiie S; Hayashi Y
    Sci Rep Res Inst Tohoku Univ Med; 1972 Jul; 19(1):38-51. PubMed ID: 4509861
    [No Abstract]   [Full Text] [Related]  

  • 43. [Therapy of acute leukemias in children. 1].
    Jacquillat C; Weil M; Schaison G; Delobel J; Bussel A; Brunel-Kotschi R; Gemon MF; Loisel JP
    Med Klin; 1972 Aug; 67(31):1011-7. PubMed ID: 4506638
    [No Abstract]   [Full Text] [Related]  

  • 44. [Preliminary results of the clinical study of a Soviet--produced L-asparaginase from E. coli].
    Kondrat'eva NA; Lorie IlI ; Kruglova GV; Vorob'ev AI; Koshel' IV
    Antibiotiki; 1977 Sep; 22(9):852-7. PubMed ID: 334060
    [No Abstract]   [Full Text] [Related]  

  • 45. A summary of the clinical status of asparaginase.
    Burchenal JH
    Recent Results Cancer Res; 1970; 33():350-4. PubMed ID: 5292724
    [No Abstract]   [Full Text] [Related]  

  • 46. [L-asparaginase in the treatment of acute leukoses].
    Storti E; Fontana G; Ascari E; Lusvarghi E; Silingardi V; Quaglino D; Sgandurra A; Barbieri U; Traldi A
    Minerva Med; 1970 Sep; 61(71):3635-42. PubMed ID: 5271737
    [No Abstract]   [Full Text] [Related]  

  • 47. [Coagulopathy in acute lymphoblastic leukemia (ALL) after chemotherapy].
    Morisaki T; Kumakawa T; Kodo H; Fujii H; Asano S; Sato Y; Homma T; Tada A; Mori S; Miwa S
    Rinsho Ketsueki; 1985 Nov; 26(11):1763-6. PubMed ID: 3869657
    [No Abstract]   [Full Text] [Related]  

  • 48. L-asparaginase: clinical, biochemical, pharmacological, and immunological studies.
    Capizzi RL; Bertino JR; Skeel RT; Creasey WA; Zanes R; Olayon C; Peterson RG; Handschumacher RE
    Ann Intern Med; 1971 Jun; 74(6):893-901. PubMed ID: 5281051
    [No Abstract]   [Full Text] [Related]  

  • 49. [Metabolism of blood leukocytes in patients with malignant hemopathies and hematosarcomas during the course of chemotherapy].
    Lille I; Gabay P; Clavel B; Saracino RT; Bourdin JS
    Nouv Rev Fr Hematol; 1969; 9(5):715-21. PubMed ID: 4244273
    [No Abstract]   [Full Text] [Related]  

  • 50. [Rimactan (rifampicin) and anticoagulant therapy].
    Michot F; Bürgi M; Büttner J
    Schweiz Med Wochenschr; 1970 Mar; 100(13):583-4. PubMed ID: 5420855
    [No Abstract]   [Full Text] [Related]  

  • 51. Achromobacter L-glutaminase-L-asparaginase: human pharmacology, toxicology, and activity in acute leukemias.
    Spiers AS; Wade HE
    Cancer Treat Rep; 1979 Jun; 63(6):1019-24. PubMed ID: 288507
    [No Abstract]   [Full Text] [Related]  

  • 52. L-asparaginase in treatment of acute leukaemia and lymphosarcoma.
    Beard ME; Crowther D; Galton DA; Guyer RJ; Fairley GH; Kay HE; Knapton PJ; Malpas JS; Scott RB
    Br Med J; 1970 Jan; 1(5690):191-5. PubMed ID: 4904933
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Combined treatment of acute leukemia with L-asparaginase and daunomycin].
    Gerhartz H
    Haematol Lat; 1969; 12(3):821-7. PubMed ID: 5273188
    [No Abstract]   [Full Text] [Related]  

  • 54. Therapy of adult acute leukemia with daunorubicin and L-asparaginase.
    Bodey GP; Hewlett JS; Coltman CA; Rodriguez V; Freireich EJ
    Cancer; 1974 Mar; 33(3):626-30. PubMed ID: 4521886
    [No Abstract]   [Full Text] [Related]  

  • 55. Normotest in acute viral hepatitis.
    Schmidt W; Gros H
    Scand J Gastroenterol Suppl; 1973; 19():143-50. PubMed ID: 4515638
    [No Abstract]   [Full Text] [Related]  

  • 56. L-asparaginase in treatment of acute leukemia in children.
    Misíková Z; Cáp J
    Neoplasma; 1978; 25(1):133-9. PubMed ID: 273152
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Immunization against L-asparaginase. Demonstration and characteristics of antibodies. Clinical value].
    Marsalet YD; Lambert G; Hornez JP; Bauters F; Goudemand M
    Nouv Presse Med; 1973 Jun; 2(23):1575-8. PubMed ID: 4197351
    [No Abstract]   [Full Text] [Related]  

  • 58. Analysis of long-term survival in acute leukemia and Burkitt's tumor--effects to be expected from intensive therapy and asparaginase.
    Burchenal JH
    Proc Natl Cancer Conf; 1970; 6():127-32. PubMed ID: 5272230
    [No Abstract]   [Full Text] [Related]  

  • 59. Therapy of acute leukemia with the combination of cytosine arabinoside (NSC-63878) and cyclophosphamide (NSC-26271).
    Bodey GP; Rodriguez V; Hart J; Freireich EJ
    Cancer Chemother Rep; 1970 Aug; 54(4):255-62. PubMed ID: 4946010
    [No Abstract]   [Full Text] [Related]  

  • 60. Comparison of CNS-leukaemia in children with acute leukaemia, induced either with rubidomycin or L-asparaginase.
    de Vaan GA; Marcar JR; Schretlen ED
    Padiatr Padol; 1971; 6(3):230-9. PubMed ID: 5293526
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.